WallStreetZenWallStreetZen

NASDAQ: CERT
Certara Inc Stock Forecast, Predictions & Price Target

Analyst price target for CERT

Based on 7 analysts offering 12 month price targets for Certara Inc.
Min Forecast
$19.00-2.71%
Avg Forecast
$21.86+11.92%
Max Forecast
$26.00+33.13%

Should I buy or sell CERT stock?

Based on 7 analysts offering ratings for Certara Inc.
Buy
Strong Buy
3 analysts 42.86%
Buy
2 analysts 28.57%
Hold
2 analysts 28.57%
Sell
0 analysts 0%
Strong Sell
0 analysts 0%

Be the first to know when Wall Street analysts revise their CERT stock forecasts and price targets.

CERT stock forecasts by analyst

Analyst / FirmRatingActionPrice TargetUpside/DownsideDateAnalyst Color
Barclays
Bottom 2%
2
Strong BuyMaintains$20.00+2.41%2023-01-24
Baird
Top 7%
94
HoldDowngrades$19.00-2.71%2022-12-14
Credit Suisse
Top 7%
94
BuyMaintains$20.00+2.41%2022-11-14
Berenberg
Bottom 12%
12
Strong BuyInitiates Coverage On$23.00+17.77%2022-09-08
Morgan Stanley
Bottom 9%
9
HoldMaintains$20.00+2.41%2022-08-24
Piper Sandler
Bottom 6%
6
Strong BuyMaintains$25.00+28.01%2022-08-10
SVB Leerink
Bottom 29%
29
BuyMaintains$26.00+33.13%2022-08-10

1 of 1

Forecast return on equity

Is CERT forecast to generate an efficient return?
Company
N/A
Industry
-0.01%
Market
13.24%

Forecast return on assets

Is CERT forecast to generate an efficient return on assets?
Company
N/A
Industry
0.12%

CERT earnings per share forecast

What is CERT's earnings per share in the next 3 years based on estimates from 3 analysts?
Avg 1 year Forecast
$0.43
Avg 2 year Forecast
$0.76
Avg 3 year Forecast
$0.89

CERT revenue forecast

What is CERT's revenue in the next 3 years based on estimates from 4 analysts?
Avg 1 year Forecast
$376.7M+16.13%
Avg 2 year Forecast
$443.6M+36.78%
Avg 3 year Forecast
$532.2M+64.08%
CERT's revenue is forecast to... subscribe to Premium to read more.
Forecast High Revenue Growth Forecast

CERT revenue growth forecast

How is CERT forecast to perform vs Biotechnology companies and vs the US market?
Company
17.33%
Industry
38.5%
Market
9.23%
CERT's revenues are forecast to... subscribe to Premium to read more.
Forecast Revenue Growth vs Industry Forecast
CERT's revenues are forecast to... subscribe to Premium to read more.
Forecast Revenue Growth vs Market Forecast

CERT vs Biotech Stocks

TickerPricePrice TargetUp/downsideConsensus
CERT$19.53$21.86+11.92%Buy
IMCR$64.29$79.00+22.88%Strong Buy
ABCL$11.18$26.60+137.92%Strong Buy
RARE$45.73$95.79+109.46%Strong Buy
MRTX$52.57$77.92+48.22%Buy

Certara Stock Forecast FAQ

Is Certara Stock a good buy in 2023, according to Wall Street analysts?

The consensus among 7 Wall Street analysts covering (NASDAQ: CERT) stock is to Buy CERT stock.

Out of 7 analysts, 3 (42.86%) are recommending CERT as a Strong Buy, 2 (28.57%) are recommending CERT as a Buy, 2 (28.57%) are recommending CERT as a Hold, 0 (0%) are recommending CERT as a Sell, and 0 (0%) are recommending CERT as a Strong Sell.

If you're new to stock investing, here's how to buy Certara stock.

What is CERT's earnings growth forecast for 2023-2025?

(NASDAQ: CERT) Certara's forecast annual earnings growth rate of N/A is not forecast to beat the US Biotechnology industry's average forecast earnings growth rate of 5.4%, and while it is not forecast to beat the US market's average forecast earnings growth rate of 21.99%.

Certara's earnings in 2023 is -$4,142,000.On average, 3 Wall Street analysts forecast CERT's earnings for 2023 to be $68,659,389, with the lowest CERT earnings forecast at $55,885,549, and the highest CERT earnings forecast at $91,013,608. On average, 1 Wall Street analyst forecast CERT's earnings for 2024 to be $121,351,478, with the lowest CERT earnings forecast at $121,351,478, and the highest CERT earnings forecast at $121,351,478.

In 2025, CERT is forecast to generate $142,108,967 in earnings, with the lowest earnings forecast at $142,108,967 and the highest earnings forecast at $142,108,967.

What is CERT's revenue growth forecast for 2023-2025?

(NASDAQ: CERT) Certara's forecast annual revenue growth rate of 17.33% is not forecast to beat the US Biotechnology industry's average forecast revenue growth rate of 38.5%, and while it is forecast to beat the US market's average forecast revenue growth rate of 9.23%.

Certara's revenue in 2023 is $324,357,000.On average, 4 Wall Street analysts forecast CERT's revenue for 2023 to be $60,143,229,415, with the lowest CERT revenue forecast at $58,611,167,009, and the highest CERT revenue forecast at $61,027,019,453. On average, 3 Wall Street analysts forecast CERT's revenue for 2024 to be $70,837,807,408, with the lowest CERT revenue forecast at $68,951,590,295, and the highest CERT revenue forecast at $73,465,545,920.

In 2025, CERT is forecast to generate $84,977,969,003 in revenue, with the lowest revenue forecast at $84,977,969,003 and the highest revenue forecast at $84,977,969,003.

What is CERT's forecast return on assets (ROA) for 2023-2026?

(NASDAQ: CERT) forecast ROA is N/A, which is lower than the forecast US Biotechnology industry average of 0.12%.

What is CERT's Price Target?

According to 7 Wall Street analysts that have issued a 1 year CERT price target, the average CERT price target is $21.86, with the highest CERT stock price forecast at $26.00 and the lowest CERT stock price forecast at $19.00.

On average, Wall Street analysts predict that Certara's share price could reach $21.86 by Jan 24, 2024. The average Certara stock price prediction forecasts a potential upside of 11.92% from the current CERT share price of $19.53.

What is CERT's Earnings Per Share (EPS) forecast for 2023-2025?

(NASDAQ: CERT) Certara's current Earnings Per Share (EPS) is -$0.03. On average, analysts forecast that CERT's EPS will be $0.43 for 2023, with the lowest EPS forecast at $0.35, and the highest EPS forecast at $0.57. On average, analysts forecast that CERT's EPS will be $0.76 for 2024, with the lowest EPS forecast at $0.76, and the highest EPS forecast at $0.76. In 2025, CERT's EPS is forecast to hit $0.89 (min: $0.89, max: $0.89).

What is CERT's forecast return on equity (ROE) for 2023-2026?

(NASDAQ: CERT) forecast ROE is N/A, which is considered weak.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.